Investor Ideas #Potcasts;
#Cannabis News and #Stocks on the Move; (NASDAQ: $HUGE) (CSE: $HUGE.C), (NASDAQ:
$SNDL), (CSE: $TGIF.C)
Delta, Kelowna, BC,
January 10, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its
potcast site, www.potcasts.ca release today’s podcast edition of cannabis news
and stocks to watch plus insight from thought leaders and experts.
Listen to the
podcast:
Read this in full at
Today’s podcast
overview/transcript:
Good afternoon and
welcome to another episode of Investorideas.com "Potcast" featuring
cannabis news, stocks to watch as well as insights from thought leaders and
experts.
In today’s podcast we
look at a few early announcements.
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) announced that its Class B Subordinate Voting Shares will
commence trading on the Nasdaq Capital Market under the symbol 'HUGE' today,
January 9, 2020. The Company's Class B Subordinate Voting Shares will continue
to trade on the Canadian Securities Exchange under the symbol 'HUGE'.
"The listing of our
shares on the Nasdaq Capital Market is a momentous moment and represents a
paradigm shift in the outlook of FSD Pharma," said Dr. Raza Bokhari, Executive
Co-Chairman and CEO. "Doing so offers us an opportunity to expand
awareness of the company's specialty pharmaceutical lead asset, a micronized
formulation of palmitolylethonalamide (micro-PEA), which by targeting the CB2
receptor of the endocannabinoid system of the human body, may help address the
opioid crisis by developing opioid-sparing, FDA-approved prescription drugs. A
NASDAQ listing also elevates our corporate profile to institutional
investors."
Dr. Bokhari will present
at Biotech Showcase 2020 in San Francisco on Monday, January 13, 2020 at 3:30
pm PT where he will provide an overview of the Company, as well as recent
strides made to transform FSD Pharma into a specialty pharmaceutical R&D
company.
Sundial Growers
Inc. (NASDAQ: SNDL), a Canadian licensed cannabis
producer and Vir Pharma Holdings Pty Ltd. (NASDAQ: VIR), an Australian importer and
manufacturer of medical cannabis, today announced a three-year agreement where Sundial
will supply medical cannabis oil for Vir Pharma's unique oral formulation for
chronic pain that will be used for sales and clinical studies in Australia.
Vir Pharma's clinical
studies contribute to the development of a proprietary cannabis-based
prescription drug for Therapeutic Goods Administration (TGA) approval called
Virabis. The drug is intended to treat chronic pain, providing patients with an
alternative to current opioid-based treatments.
"This is a
significant announcement for Sundial and our Heal (medical) business as it will
lead to our first global exports and entry into Australian markets," said
Brian Harriman, Chief Operating Officer of Sundial. "We're excited to be
working with a leading company such as Vir Pharma to provide Australian
patients with high-quality, cannabis-based therapies."
Pursuant to the
Agreement, Sundial will work with Vir Pharma to develop a cannabis oil blend
focused on chronic pain, which will be marketed under Vir Pharma's brand name,
Virabis.
"At Vir Pharma, we
believe that full spectrum cannabis medicines could be a useful second line
therapy to reduce opiate consumption and enhance the lives of people living in
chronic pain," said Joel Hardy, CEO. "This agreement provides us a
high-quality and consistent supply of GMP cannabis oil that allows us to
guarantee a quality supply chain of materials to create products for sale in
Australia and to conduct a clinical development program."
The relationship between
Sundial and Vir Pharma will enable shared learnings and capabilities, allowing
both parties to leverage each other's expertise and opening the door to
developing innovative medical cannabis therapies moving forward.
1933
Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated and
growth-orientated cannabis consumer packaged goods company, announced a licensing agreement between the Company's
subsidiary, Alternative Medicine Association LLC and Capna Intellectual, Inc.,
developer of The Bloom Brand. The one-year agreement was executed in December
and received state approval in January, and awards AMA the exclusive license to
manufacture a wide range of Bloom™ products for the Nevada market.
Established
in California in 2014, Bloom™ is now sold in over three hundred licensed
retailers in California, Nevada, Washington and New Mexico, with further
expansion planned for new markets in Oklahoma, Massachusetts and Canada.
In
2015, AMA was the first licensed cultivator in Southern Nevada. Today, AMA
continues its tradition of cultivating craft cannabis in a newly-constructed,
state-of-the-art, purpose-built facility in Las Vegas, offering consistency and
scalability. Well-known for its premium quality cannabis products, AMA produces
a variety of THC concentrates, as well as oils used in vape pen cartridges,
with a variety of terpene profiles for flavours and aromas.
"Our
companies focus on end-use cannabis products that provide the highest quality
ingredients and that are safe for consumers", remarked Ms. Ester Vigil,
President of 1933 Industries. "Our goal is to expand beyond our
proprietary AMA products and represent the very best cannabis brands in Nevada,
offering a full suite of differentiated product lines. Bloom™ is a brand we
have been watching for some time, waiting for the opportune time to work
together. We are impressed by the professionalism of the Bloom™ team and we are
proud to represent such a highly rewarded brand in Nevada", Ms. Vigil
continued.
Providing
an experience that is as close to the cannabis plant as possible and delivered
in a tasteful and convenient way, the Bloom™ licensed products include:
·
Bloom™ Vape –
Original vapor method available in a 500mg cartridge
·
Bloom™ One –
Disposable vapor method providing the same flavorful experience in a smaller,
350mg preloaded, disposable package
·
Bloom™ Dart – Pod
vapor method includes CCELL's advanced ceramic heating elements for greater oil
absorption
·
Bloom™ Drop – Oil
infusion method comes with 800mg of oil with pre-activated THC. The oil can be
added to flower, dabs or for infusing food for instant effects
·
Bloom™ Kit –
Pocket-sized vape battery for Bloom cartridges, featuring a sleek buttonless
design, which activates as one inhales
Bloom™
products do not contain any additives, PG, VG, or vitamin E Acetate.
"Consistency is at the core of
everything we do, so it was integral for us to find the right partners to act
as an extension of our vision," said CEO and co-founder of Bloom™, Mr.
Vitaly Mekk, "We are thrilled to begin this partnership with 1933. Their
extensive cannabis history and experience in Nevada give us confidence that we
will be able to achieve our goals together."
Lastly Lift and Co 2020 in Vancouver
kicked off to an optimistic start yesterday as speakers and panelists discussed
the future of Cannabis 2.0 products, the Future of Psychedelics, Rebuilding
Trust and Confidence and ended with a panel discussion on international markets
over the next 12 months. Investorideas was live at the event and we have
included a brief excerpt of the final panel which features Deepak Anand,
Founder and CEO of Materia Venture and Zamina Walgi, VP of Retail and Consumer
Markets Strategy of Aurora Cannabis, Andrew Miller, Head of Cannabis Business
Development at Clever Leaves and Rosy Mondin, CEO of World Class Extractions.
Investorideas will also be conducting
live interviews at Lift and Co Vancouver 2020 today.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website
and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Investorideas.com
podcasts are also available on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and
Tunein.
Potcasts
is now a certified word mark Trademark on the blockchain through Cognate, Inc.
CM Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and videos,
looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play by Play
sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech and
Climate Change , Exploring Mining
the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on
Cannabis Social Media
Contact
Investorideas.com
800-665-0411
No comments:
Post a Comment